LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Genetic Remodeling Transforms E. Coli into Intestinal Pathogen

By LabMedica International staff writers
Posted on 09 Mar 2017
Print article
Image: A low-temperature scanning electron micrograph (SEM) of a cluster of E. coli bacteria, magnified 10,000 times (Photo courtesy of the USDA).
Image: A low-temperature scanning electron micrograph (SEM) of a cluster of E. coli bacteria, magnified 10,000 times (Photo courtesy of the USDA).
A team of molecular microbiologists has traced the genetic steps that enable the common bacteria Escherichia coli to transform from a commensal organism into a pathogenic one.

Enteropathogenic Escherichia coli (EPEC), the cause of severe intestinal infection, employ a type III secretion system (T3SS) to inject effector proteins into intestinal epithelial cells. These effectors subvert host cell processes to promote bacterial colonization.

Investigators at the Hebrew University of Jerusalem showed that the T3SS also functioned to sense the host cell and to trigger in response posttranscriptional remodeling of gene expression in the bacteria. They further showed that upon effector injection, the effector-bound chaperone (CesT), which remained in the EPEC cytoplasm, antagonized the posttranscriptional regulator CsrA.

In obtaining these results, the investigators showed that after attaching to the host by means of pili, the bacteria sensed attachment to the human intestinal cells and activated gene expression in response. This was demonstrated by engineering one of these genes to express a protein that stained the expressing bacteria to appear green under the microscope. Under microscopic examination, the investigators observed that only the attached bacteria fluoresced in bright green, whereas non-attached bacteria remained dark.

"The next steps include mapping in detail the genes that change their expression upon attachment, and describing the precise effects of this expression remodeling,” said senior author Dr. Ilan Rosenshine, professor of bacteriology at the Hebrew University of Jerusalem. “Another important issue is testing whether similar regulation is involved in the infection processes of other pathogens."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more